Immunological biotechnology enables developing strategies for dissecting and manipulating molecular processes in health and disease and is a crucial approach for establishment and optimisation of tools for therapeutic intervention as well as diagnostics.
Central for our research is the molecular access to the disease and a mechanism-driven development of biologicals at the interface of immunology, protein biochemistry, biotechnology, and chemistry. Within this concept the specific needs for patient tailored, precision medical treatment are addressed.
